BIOVENTIX
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Jan 2032: the §8 declaration of use).
Record
- Serial number
- 98560610
- Registration number
- 8113369
- Mark type
- Word mark
- Filed
- 21 May 2024
- Published for opposition
- 09 Dec 2025
- Registered
- 27 Jan 2026
- Next maintenance filing
- §8 declaration of use, due by 27 Jan 2032 (grace period to 27 Jul 2032)
- Attorney of record
- Christopher D. Casavale
Goods and services
- Class 001 — Chemicals: Chemicals preparations for use in industry, science and photography, as well as in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticide; antibody reagents used for detection of antigens in cells and tissue, other than for medical or veterinary purposes; monoclonal antibody reagents, other than for medical or veterinary purposes; monoclonal antibodies for scientific purposes; Chemical preparations, namely, radio-labelled monoclonal antibody for industrial or scientific use and not for medical or veterinary purposes; Chemical preparations, namely, radio-labelled monoclonal antibody for industrial or scientific use for medical or diagnostic purposes; reagents for scientific and research use, namely, reagents for development of monoclonal antibodies other than for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Sanitary preparations for medical purposes; antibodies for medical purposes; antibody fragments for medical purposes; antibody reagents used for detection of antigens in cells and tissue, for medical and diagnostic purposes; antibodies and antibody fragments for medical and veterinary diagnostics; antibodies and antibody fragments for use in the discovery, preclinical and clinical development of medical therapeutic products; biological indicators for use in medical diagnosis of diseases, deficiencies, organ disease and disfunction, cancer, fertility issues, for medical purposes ; reactants for use in medical diagnosis, in the nature of substances or compounds that can facilitate a reaction for use in medical tests, for use in medical diagnosis of diseases, deficiencies, organ disease and disfunction, cancer, fertility issues, for medical purposes; medical reagents for use in the development of monoclonal antibodies for medical purposes; veterinary reagents for use in the development of monoclonal antibodies for veterinary purposes; diagnostic reagents for medical diagnostics and medical use, veterinary diagnostics and veterinary use, clinical diagnostics and clinical use and chemical testing
Owner
- Bioventix PLC, London, GB
- Bioventix PLC, London, GB
- Bioventix PLC, London, GB
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Nov 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 28 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Sept 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 30 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Mar 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 31 Mar 2025 — FINAL REFUSAL E-MAILED
- 31 Mar 2025 — FINAL REFUSAL WRITTEN